ADVIA Centaur XPT Immunoassay System
Vitamin D Total
High-Sensitivity Troponin I (TNIH)
HIV 1/O/2 Enhanced (EHIV)§
Enhanced Liver Fibrosis (ELF™) Test†
HA (ELF™ Marker)†
PIIINP (ELF™ Marker)†
TIMP (ELF™ Marker)†
Therapeutic Drug Monitoring (TDM)
* Under development. Not available for sale.
† Not available for sale in the U.S.
‡CA 125II is a trademark of Fujirebio Diagnostics, Inc.
§ Assay developed, manufactured, and sold by Siemens Healthcare Diagnostics Inc. for Ortho Clinical Diagnostics, Inc. and Grifols Diagnostic Solutions Inc.
** For outside of the U.S. only, assay developed, manufactured, and sold by Siemens Healthcare Diagnostics Inc. for Ortho Clinical Diagnostics, Inc. and Grifols Diagnostic Solutions Inc.
†† The ADVIA Centaur Zika Test has not been FDA cleared or approved. This test has been authorized by FDA under an EUA for use by authorized laboratories. This test has been authorized only for the diagnosis for Zika virus infection and not for any other viruses or pathogens. This test is only authorized for the duration of the declaration that circumstances exist justifying the authorization of the emergency use of in vitro diagnostic tests for detection of Zika virus and/or diagnosis of Zika virus infection under section 564(b)(1) of the Act, 21 U.S.C. § 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner
‡‡For Research Use Only in the U.S. Not for use in clinical or diagnostic procedures in the U.S.
The products/features (mentioned herein) are not commercially available in all countries. Due to regulatory reasons their future availability cannot be guaranteed. Please contact your local Siemens organization for further details.